Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).
The Merck has reveal Aptegra™ CHO genetic stability assay, a groundbreaking all-in-one solution that enhances biosafety testing. This innovative assay uses whole genome sequencing and bioinformatics...
Legend Biotech Corporation has developed CARVYKTI®, a breakthrough therapy approved by the U.S. Food and Drug Administration for treating relapsed or refractory multiple myeloma....
Bristol Myers Squibb has recently announced the U.S. Food and Drug Administration accelerated approval of Breyanzi®, a CD19-directed chimeric antigen receptor...
The University of Chicago Medicine is set to prescribe Resmetirom, a groundbreaking drug marketed as Rezdiffra. For the treatment of advanced metabolic dysfunction-associated steatotic liver disease...
Researchers at Stanford Medicine and McMaster University are addressing the global challenge of antibiotic resistance using generative artificial intelligence....
Johnson & Johnson revealed that the U.S. Food and Drug Administration has granted approval for the use of RYBREVANT® in combination with chemotherapy as a first-line treatment for patients diagnosed...
Merck, has announced that the U.S. Food and Drug Administration (FDA) has granted approval for sotatercept-csrk under the brand name WINREVAIR™. ...
Researchers at the College of Medicine are pioneering a new approach to combat glioblastoma, an aggressive and currently incurable form of brain cancer. Despite existing treatments such as surgery, radiation, and chemotherapy, patients typically face a grim...
Biogen recently announced a groundbreaking development: the European Commission has officially authorized SKYCLARYS® for treating Friedreich’s ataxia in adults and adolescents aged 16 years and older. This marks a significant step forward as...
Mabwell, an innovative biopharmaceutical company boasting a comprehensive industry chain, has received approval from the U.S. Food and Drug Administration for its clinical trial application of a novel B7-H3 targeting ADC, known as 7MW3711. This ADC,...
